We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ELADYNOS (Theramex Australia Pty Ltd)
Product name
ELADYNOS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 (175 working days)
Active ingredients
abaloparatide
Registration type
NCE/ NBE
Indication
ELADYNOS is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.